This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sorum, P. C. Articles by Cogneau, J. Search for Related Content PubMed PubMed Citation Articles by Sorum, P. C. Articles by Cogneau, J. Pubmed/NCBI databases Medline Plus Health Information Health Screening Prostate Cancer Social Bookmarking                         What's this?

Avoidance of Anticipated Regret: The Ordering of Prostate-Specific Antigen Tests

Etienne Mullet, PhD

Junseop Shim, PhD

Sylvie Bonnin-Scaon, PhD

Gérard Chasseigne, PhD

Joël Cogneau, MD

Objective. When making decisions, people are known to try to minimize the regret that would be provoked by unwanted consequences of these decisions. The authors explored the strength and determinants of such anticipated regret in a study of physicians’ decisions to order prostate-specific antigen (PSA) tests. Methods. 32 US and 33 French primary care physicians indicated the likelihood they would order a PSA for 32 hypothetical men presenting for routine physical exams. They then indicated how much regret they would feel if they found advanced prostate cancer in 12 other patients for whom they had chosen not to order PSAs several years before. The latter patients differed according to age (55, 65, or 75 years), a prior request or not for PSA testing, and no or some irregularity of the prostate on the earlier rectal exam. Results. ANOVA found that regret was higher when the patient had requested a PSA, the prostate was irregular, and the patient was younger. Shape had less effect when the patient had requested a PSA. US physicians had more regret than the French, patient request had a greater impact on the Americans, and increasing patient age reduced regret more among the French. In a 1-way correlation, the regret score was associated with the likelihood of ordering PSAs for both the French (r = 0.64, P < 0.005) and the Americans (r = 0.42, P< 0.02). In a regression analysis too, the regret score was the most important predictor of the likelihood of ordering a PSA (ß = 0.37, P < 0.0001). Conclusions. Regret over failing to diagnose aggressive prostate cancer is associated with a policy of ordering PSAs. This regret appears to be culturally sensitive.

Key Words: regret • anticipated regret • prostate-specific antigen • physician decision making

Medical Decision Making, Vol. 24, No. 2, 149-159 (2004)
DOI: 10.1177/0272989X04263163


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?